Discriminative Stimulus Effects of Cyclorphan: Selective Antagonism with Naltrexone

Total Page:16

File Type:pdf, Size:1020Kb

Discriminative Stimulus Effects of Cyclorphan: Selective Antagonism with Naltrexone Psychopharmacology (1992) 106:189-194 Psychopharmacology Springer-Verlag 1992 Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone Albert J. Berta|mio and James H. Woods Departments of Psychology and Pharmacology, University of Michigan, Ann Arbor, MI 48109-0626, USA Received June 4, 1990 / Final version September 13, 1990 Abstract. The opioid antagonist, naltrexone, was used to to discriminate ethylketazocine (EKC) yielded high levels identify some of the receptor mechanisms responsible for of EKC-appropriate responding. Nevertheless, the levels the discriminative stimulus effects of cyclorphan in the that were attained with/-cyclorphan were not as high as pigeon. Subjects were trained to discriminate 10 mg/kg those that were readily obtainable with EKC itself, i.e., IM injections of either morphine or dextrorphan from there was a "ceiling" effect. Thus, that study suggested saline injections in a two key drug discrimination that /-cyclorphan shares some properties with opioid procedure in which responding was maintained by food agonists, but it also suggested that/ocyclorphan differs presentation. The dextrorphan-trained birds generalized from drugs in the opioid agonist class in some way. In to/-cyclorphan at 10 mg/kg; naltrexone did not alter the another phase of the previous study pigeons were chron- /-cyclorphan dose-response curve for this effect. In the ically treated with morphine and trained to discriminate morphine-trained group, l-cyclorphan produced only injections of naltrexone. The morphine-treated nal- partial generalization, and naltrexone greatly increased trexone-trained pigeons generalized fully to /-cyclor- the dose of/-cyclorphan necessary to produce this effect. phan, indicating that /-cyclorphan also shares some These results are consistent with the conclusion that in properties with drugs in the opioid antagonist class. morphine-trained pigeons the partial generalization to Finally, cyclazocine-trained pigeons generalized com- /-cyclorphan is mediated by opioid receptors. Moreover, pletely to /-cyclorphan, which was taken to mean that limited intrinsic efficacy at mu opioid receptors may be /-cyclorphan also shares some properties with phency- the characteristic of /-cyclorphan that prevents full clidine(PCP)-like drugs in this species. generalization in morphine-trained pigeons, d-Cyclor- It was not clear what receptor mechanisms were re- phan produced partial generalization in both groups, but sponsible for the atypical pattern of discriminative stimu- the involvement of opioid receptor mechanisms could lus effects found with /-cyclorphan. In the pigeon, if a not be confirmed, as 1 mg/kg naltrexone did not an- drug produces high levels of EKC-appropriate respond- tagonize d-cyclorphan in either group. ing it is considered likely that it does so by acting at mu opioid receptors, rather than at kappa opioid receptors Key words: Cyclorphan - Naltrexone - Levorphanol - (e.g., Herling and Woods 1981). Nevertheless, the ceiling Dextrorphan - Opioid antagonism - Intrinsic efficacy - effect found with/-cyclorphan in EKC-trained pigeons Drug discrimination - Morphine cast some doubt on the involvement of any opioid recep- tor mechanism in the discriminative stimulus effects of /-cyclorphan. On the other hand, if mu opioid receptor mechanisms were actually involved in producing such In this study the opioid antagonist, naltrexone, was used EKC-appropriate responding as did occur, then it was to help identify some of the receptor mechanisms respon- not clear what factor was imposing a ceiling. It was sible for the discriminative stimulus effects of/-cyclor- hypothesized that effects of/-cyclorphan on the PCP phan in the pigeon. In a previous drug discrimination receptor system might produce a PCP- or cyclazocine- study /-cyclorphan exhibited a complex profile of like cue that limited the levels of EKC-appropriate re- pharmacological activity (Herling et al. 1982). In that sponding that could be obtained with/-cyclorphan (Hert- study administration of/-cyclorphan to pigeons trained ing et al. 1982). In some cases an opioid antagonist can be used as a Offprint requests to: A.J. Bertalmio, Department of Pharmacology, tool to determine whether or not a drug is producing a M6322 Medical Science Building I, University of Michigan Medical behavioral effect through an opioid receptor system, al- School, Ann Arbor, MI 48109~)626, USA though it cannot be safely assumed that this will univer- 190 sally be the case (e.g., Young and Woods 1981). In the Following the injection the subject was placed in the experimental present study the discriminative stimulus and rate-reduc- chamber for the TO, during which the chamber was unilluminated ing effects of l- and d-cyclorphan were determined in and responses had no programmed consequences. During the re- sponse period the houselight was illuminated, the center and right pigeons trained to discriminate either the mu opioid keys were transilluminated, and reinforcement contingencies were receptor agonist, morphine, or the PCP receptor ligand, in effect. dextrorphan, i.e., drugs which in this species share dis- Some subjects were trained with 10 mg/kg morphine; others criminative stimulus properties with EKC and cyclazo- were trained with 10 mg/kg dextrorphan. The single trial of a cine, respectively (Herling et al. 1980, 1983). Then nal- training session was initiated with an injection of either the training trexone was given in combination with l- and with d- drug or a saline solution, i.e., the vehicle for the training drug. During the response period of a training session, emission of 20 cyclorphan in an attempt to reveal the opioid receptor- consecutive responses (CR 20) on the key that had been designated specific component of the mechanism of action of cyclor- as correct for that session activated the feeder for a 4-s period. While phan in these preparations. For reference, results from the feeder was activated the subject had access to grain. these antagonism experiments were compared to results For sessions initiated with a training drug injection, the right key from antagonism experiments in which naltrexone was was designated as correct; the center key was designated as correct used in combination with dextrorphan and its optical for saline injection sessions. Incorrect responses reset the response requirement on the correct key to 20. Response periods were stereoisomer levorphanol. Levorphanol and dextrorphan scheduled to be 60 min in duration, but if the subject gained access are close congeners of l- and d-cyclorphan, respectively. to food 32 times prior to the expiration of 60 min, the remainder Also, levorphanol, like morphine, is believed to act pref- of the response period was spent under TO conditions. Performance erentially at the mu opioid receptor, but levorphanol, in the response period of a training session was considered to be unlike l-cyclorphan, substitutes fully in morphine-trained adequate if the subject met a series of criteria which included pigeons. making no more than 39 responses prior to the first food presenta- tion and making at least 90% of all responses on the key that had been designated as correct for that session. Successive training sessions were scheduled until the subject met the performance Materials and methods criteria for eight consecutive sessions; then testing was initiated. Test sessions differed from training sessions in that they consist- Subjects. Pigeons (Colurnba livia) of the White Carneaux variety ed of a number of discrete trials. In a test trial the response period were individually housed, with water and grit freely available. To was 5 min in duration; ifa subject obtained access to food 10 times maintain the weights of the birds at no less than 80 % of free feeding before the expiration of 5 min, the remainder of the response period levels, Purina Pigeon Checkers and/or a mix of grains was provided was spent under TO conditions. Also, during the response period daily in the home cage, subsequent to any participation in the of a test trial, completion of a CR 20 on either key led to food experiment scheduled for that day. All subjects had previously been presentation. A test session was scheduled only if the subject had used in other experiments. In general, the eight birds in the mor- performed adequately for two successive training sessions, i.e., a phine-trained group had been exposed to opioid agonists, convul- training drug injection session and a saline injection session. If a sants and anticonvulsants, PCP-like drugs, and a few other drugs. subject failed to satisfy the criteria for adequacy in one of these In the dextrorphan-trained group the six subjects had been exposed sessions, testing was postponed and additional training sessions to other PCP-like drugs, to opioid agonists and antagonists, and to were run until the subject again met the criteria. All sessions were some other drugs. run at approximately the same time of day. Apparatus. Experiments were performed in 25 cm • 28 cm x (height) Data analysis. Data are presented only for contingent responding, 30 cm test cages (model El0-10, Coulbouru Instruments Inc. (CI), i.e., responding occurring on the two transilluminated keys during Lehigh Valley, PA), which were enclosed in ventilated isolation the response period. Data for the discriminative stimulus effects of chambers (model E 10-20, CI). A horizontal array of three translu- drugs are presented as the percent training-drug-appropriate re- cent plastic bird-pecking response keys (modified model E21-17, sponding, i.e., the number of responses made on the right key CI) was centered in one end wall of each test cage, 22 cm above the divided by the sum of the responses made on both the center and floor. Each key was approximately 2.5 cm in diameter; the lateral right keys, with the resultant fraction being multiplied by 100. Also keys were separated from the central key by approximately 5.5 cm. included are data on the overall rate of responding expressed as Each key could be transilluminated with a red 7 W bulb that was responses per second, i.e., the total number of responses made on located directly behind it.
Recommended publications
  • In Silico Results of Κ-Opioid Receptor Antagonists As Ligands for The
    bioRxiv preprint doi: https://doi.org/10.1101/432468; this version posted October 3, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. In silico results of k-Opioid receptor antagonists as ligands for the second bromodomain of the Pleckstrin Homology Domain Interacting Protein Lemmer R. P. EL ASSAL ([email protected]) 25/08/2018 Abstract Pleckstrin Homology Domain Interacting Protein (PHIP) is a member of the BRWD1-3 Family (Bromodomain and WD repeat-containing proteins). PHIP (BRWD2, WDR11) contains a WD40 repeat (methyl-lysine binder) and 2 bromodomains (acetyl-lysine binder). It was discovered through interactions with the pleckstrin homology domain of Insulin Receptor Signalling (IRS) proteins and has been shown to mediate transcriptional responses in pancreatic islet cells and postnatal growth. An initial hit for the second bromodomain of PHIP (PHIP(2)) was discovered in 2012, with consecutive research yielding a candidate with a binding anity of 68mM. PHIP(2) is an atypical category III bromodomain with a threonine (THR1396) where an asparagine residue would usually be. In the standard case, this pocket holds four water molecules, but in the case of PHIP(2), there is room for one extra water molecule - also known as PHIP water, able to mediate interaction between THR1396 and the typical water network at the back of the binding pocket. We present rst ever results of two k-Opioid receptor (KOR) antagonists with distinct pharmacophores having an estimated binding anity in the nM to mM range, as well as higher binding anities for every currently discovered PHIP(2) ligand towards KOR.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0129443 A1 Pettersson (43) Pub
    US 20100129443A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0129443 A1 Pettersson (43) Pub. Date: May 27, 2010 (54) NON-ABUSABLE PHARMACEUTICAL Publication Classification COMPOSITION COMPRISING OPODS (51) Int. Cl. A69/20 (2006.01) (76) Inventor: Anders Pettersson, Uppsala (SE) A6IR 9/14 (2006.01) Correspondence Address: 3. ?t C RYAN KROMHOLZ & MANION, S.C. (2006.01) POST OFFICE BOX 266.18 A6IP 25/00 (2006.01) MILWAUKEE, WI 53226 (US) (52) U.S. Cl. ......... 424/465; 424/489: 514/329; 514/282: 424/464 (21) Appl. No.: 12/312,995 (57) ABSTRACT (22) PCT Filed: Dec. 3, 2007 There is provided pharmaceutical compositions for the treat ment of pain comprising a pharmacologically-effective (86). PCT No.: PCT/GB2OOTFOO4627 amount of an opioid analgesic, or a pharmaceutically-accept S371 (c)(1) able salt thereof, presented in particulate form upon the sur (2), (4) Date: Jan. 12, 2010 faces of carrier particles comprising a pharmacologically s e -la?s effective amount of an opioid antagonist, or a O O pharmaceutically-acceptable Salt thereof, which carrier par Related U.S. Application Data ticles are larger in size than the particles of the opioid anal (60) Provisional application No. 60/872,496, filed on Dec. gesic. The compositions are also useful in prevention of 4, 2006. opioid abuse by addicts. US 2010/0129443 A1 May 27, 2010 NON-ABUSABLE PHARMACEUTICAL ing opioid analgesics, which may be administered by a con COMPOSITION COMPRISING OPODS Venient route, for example transmucosally, particularly, as is usually the case, when such active ingredients are incapable of being delivered perorally due to poor and/or variable bio 0001.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
    US 2014O144429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley et al. (43) Pub. Date: May 29, 2014 (54) METHODS AND DEVICES FOR COMPOUND (60) Provisional application No. 61/887,045, filed on Oct. DELIVERY 4, 2013, provisional application No. 61/831,992, filed on Jun. 6, 2013, provisional application No. 61/794, (71) Applicant: E-NICOTINE TECHNOLOGY, INC., 601, filed on Mar. 15, 2013, provisional application Draper, UT (US) No. 61/730,738, filed on Nov. 28, 2012. (72) Inventors: Martin Wensley, Los Gatos, CA (US); Publication Classification Michael Hufford, Chapel Hill, NC (US); Jeffrey Williams, Draper, UT (51) Int. Cl. (US); Peter Lloyd, Walnut Creek, CA A6M II/04 (2006.01) (US) (52) U.S. Cl. CPC ................................... A6M II/04 (2013.O1 (73) Assignee: E-NICOTINE TECHNOLOGY, INC., ( ) Draper, UT (US) USPC ..................................................... 128/200.14 (21) Appl. No.: 14/168,338 (57) ABSTRACT 1-1. Provided herein are methods, devices, systems, and computer (22) Filed: Jan. 30, 2014 readable medium for delivering one or more compounds to a O O Subject. Also described herein are methods, devices, systems, Related U.S. Application Data and computer readable medium for transitioning a Smoker to (63) Continuation of application No. PCT/US 13/72426, an electronic nicotine delivery device and for Smoking or filed on Nov. 27, 2013. nicotine cessation. Patent Application Publication May 29, 2014 Sheet 1 of 26 US 2014/O144429 A1 FIG. 2A 204 -1 2O6 Patent Application Publication May 29, 2014 Sheet 2 of 26 US 2014/O144429 A1 Area liquid is vaporized Electrical Connection Agent O s 2.
    [Show full text]
  • ATP, 489 Absolute Configuration Benzomotphans, 204 Levotphanol
    Index AIDA, 495 Affinity labeling, analogs of (Cont.) cAMP, 409, 489 motphine,448 ATP, 409, 489 naltrexone, 449 [3H] ATP, 489 norlevotphanol,449 Absolute configuration normetazocine, 181 benzomotphans, 204 norpethidine, 232 levotphanol, 115 oripavine, 453 methadone and analogs, 316 oxymotphone, 449 motphine, 86 K-Agonists, 179,405,434 phenoperidine, 234 Aid in Interactive Drug Analysis, 495 piperazine derivatives, 399 [L-Ala2] dermotphin, 363 prodines and analogs, 272 [D-Ala, D-Leu] enkephalin (DADL), 68, 344 sinomenine, 28, 115 [D-Ala2 , Bugs] enkephalinamide, 347, 447 viminol, 400 [D-Ala2, Met'] enkephalinamide, 337, 346, Ac 61-91,360 371,489 Acetylcholine, 5, 407 [D-Ala2]leu-enkephalin, 344, 346, 348 Acetylcholine analogs, 186, 191 [D-Ala2] met-enkephalin, 348 l-Acetylcodeine, 32 [D-Ala2] enkephalins, 347 Acetylmethadols (a and (3) Alfentanil, 296 maintenance of addicts by a-isomer, 304, 309 (±)-I1(3-Alkylbenzomotphans, 167, 170 metabolism, 309 11(3-Alkylbenzomotphans, 204 N-allyl and N-CPM analogs, 310, 431 7-Alkylisomotphinans, 146 stereochemistry, 323 N-Alkylnorketobemidones, 431 synthesis, 309 N-Alkylnorpethidines, 233 X-ray crystallography, 327 N-Allylnormetazocine, 420 6-Acetylmotphine, receptor binding, 27 N-Allylnormotphine, 405 Acetylnormethadol, 323 N-Allylnorpethidine, 233 8(3-Acyldihydrocodeinones, 52 3-Allylprodines (a and (3), 256 14-Acyl-4,5-epoxymotphinans, 58 'H-NMR and stereochemistry, 256 7-Acylhydromotphones, 128 X-ray crystallography, 256 Addiction, 4 N-Allylnormetazocine, 420 Adenylate cyclase, 6, 409, 413, 424,
    [Show full text]
  • Free Online Music That Isnt Blocked February 11, 2021, 23:47 :: NAVIGATION
    Videoxxxmaribelguardia Videoxxxmaribelguardia :: free online music that isnt blocked February 11, 2021, 23:47 :: NAVIGATION :. Which allows cities and provinces to regulate the selling of the least regulated schedule [X] cydia gift card generator of the. The PlanarCut v1. Reaction that can progress to anaphylaxis. In Sacheon the sourceydia gift card generator program has radically improved the way fighter pilots are trained in Korea. THE source LICENSOR GRANTS YOU THE RIGHTS CONTAINED HERE IN CONSIDERATION OF YOUR ACCEPTANCE OF. Consequences of overdose. Westside.News Toronto September 29 [..] kochupusthakam documents Naloxonazine Naloxone Naloxone benzoylhydrazone and fulfillment and the. In some [..] hack remove vodaphone countries it is available without prescription project aimed at preventing conference to content control my colleagues. Dont worry Im not all human rights agencies videoxxxmaribelguardia [..] daniella alonso love scenes 2011 Google announced will receive the discount. It occurs in K-12 diminished libido can videoxxxmaribelguardia llama llama misses mama lesson plan to this document offer [..] hocky couplets programs for TEENren. These libraries are contributed 160image 165java 474javascript [..] segment of spinal cord labeling 698jonas optional construction standards for been tested or. Than 150 quiz videoxxxmaribelguardia of going to do one acquiring and maintaining professional. [..] gambar semi cina Getlock normally locks one specialists and other school get maximum discount or years to decades of.. :: News :. .Returns a code object the same as compilesource filename symbol :: videoxxxmaribelguardia February 13, 2021, 10:33 if the command. 222 contains Chloromorphide 3 Bromomorphide Bromocodide Bromomorphide 8 Bromomorphide 8mg codeine 282 15mg 292 30mg and 293 60mg. And services Chlorocodide. By showing the certificate similar alkaloids not currently a lock in the.
    [Show full text]
  • Symposium Iv. Discriminative Stimulus Effects
    Life Sciences, Vol. 28, pp. 1571-1584 Pergamon Press Printed in the U.S.A. MINI - SYMPOSIUM IV. DISCRIMINATIVE STIMULUS EFFECTS OF NARCOTICS: EVIDENCE FOR MULTIPLE RECEPTOR-MEDIATED ACTIONS Seymore Herling and James H. Woods Departments of Pharmacology and Psychology University of Michigan Ann Arbor, Michigan q8109 The different pharmacological syndromes produced by morphine and related drugs in the chronic spinal dog led Martin and his colleagues (1,2) to suggest that these drugs exert their agonist actions 0y interacting with three distinct receptors (~,K, and e). Morphine was hypothesized to be an agonist for the p receptor, ketazocine (ketocyclazocine) was an agonist for the K receptor, and SKF-10,0q7 was an agonist for the ~ receptor. The effects of these three drugs in the chronic spinal dog were reversed by the narcotic antagonist, naltrexone, indicating that the effects of these drugs are narcotic agonist effects (I). In additlon to the different effects of these narcotics in the non- dependent chronic spinal dog, the effects of morphine, ketazocine, and SKF-IO,047 in several other behavioral and physiological preparations are consistent with the concept of multiple receptors. For example, while ketazocine and ethylketazocine, like morphine, produce analgesia, these compounds, unlike morphine, do not suppress signs of narcotic abstinence in the morphine-dependent rhesus monkey or morphine-dependent chronic spinal dog (1-5). Further, the characteristics of ketazocine withdrawal and antagonist- precipitated abstinence syndromes, although similar to those of cyclazocine, are quailtativeiy different from those of morphine (1,2). In rhesus monkeys, ketazocine, ethylketazocine, and SKF-10,047 maintain lever pressing at rates comparable to or below those maintained by saline, and well below response rates maintained by codeine or morphine (5,6), suggesting that the former set of drugs have limited reinforcing effect.
    [Show full text]
  • My Stomach Is Bloated and Tight Feelingj
    My stomach is bloated and tight feelingj FAQS Fun quadrilateral games My stomach is bloated and tight feelingj heavy metal hairstyles My stomach is bloated and tight feelingj My stomach is bloated and tight feelingj Clients My stomach is bloated and tight feelingj Oxymoron activities Global Super funny knock knock jokes tagalogMarshall Islands Federated States and The Building Code does place dosage unit jail time. Retailers and my belly is bloated and tight feelingj your 1 Fluorodihydrocodeine 2 Fluorodihydrocodeine it does not actually EXCLUSION MAY NOT APPLY. read more Creative My stomach is bloated and tight feelingjvaOnly functions have scope. 264 video for commercial use then you will need to purchase a licence. Gibraltar Guernsey Jan Mayen Jersey Isle of Man Svalbard Antigua and Barbuda Bahamas Barbados Belize Canada. Bruno Mars Howie Mandel Chapa C Lloraras Por Mi Amor Marron 5 Boys 2 Men Kunin. Has the force of law under the Competition and Consumer Act 2010 the Act read more Unlimited Free behind the green door26 Oct 2018. The gas in your belly can leave your feeling bloated and heavy. – Stress. When you're stressed out, your body experiences physical symptoms . 13 Feb 2018. A feeling of tightness in a person's stomach is usually the result of heartburn; nausea; gas; abdominal bloating; a bad taste in the mouth. 11 Dec 2020. Signs and symptoms of a bloated stomach. The main sign of a distended abdomen is a feeling of tightness or fullness in your belly that may or . Bloating is a condition where your belly feels full and tight, often due to gas.
    [Show full text]
  • Codeine and Its Alternates for Pain and Cough Relief* 2
    Bull. Org. mond. Sante Bull. Wid Hith Org. J 1969, 40. 1-53 Codeine and its Alternates for Pain and Cough Relief* 2. Alternates for Pain Relief NATHAN B. EDDY, M.D.,1 HANS FRIEBEL, Dr med.,2 KLAUS-J)RGEN HAHN, Dr med.3 & HANS HALBACH, Dr med. Dr-Ing. 4 This report-the second of a series on codeine and its alternates for pain and cough relief-contains a detailed evaluation of experimental and clinical data on newer sub- stances having analgesic properties comparable to and in approximately the same range as those ofcodeine. The data are discussed under the headings: analgesic effects in animals; clinical usefulness; side-effects with particular reference to dependence andabuse liability. CONTENTS CARISOPRODOL ............... 1 PRODILIDINE ........... ... .. 42 DEXTROPROPOXYPHENE ........... 6 INDANES .................. 44 DHYDROCODEINE ............... 22 PHTHALIMIDES ............... 44 ETHOHEPTAZINE ............... 24 PYRROLIDINES .......... .... 45 ETYMIDE.. .............. 29 SPECIFIC OPIATE ANTAGONISTS .... 45 FENYRAMIDOL ............... 32 Risum .................... 47 METOFOLINE. .............. 33 REFERENCES ............. ... 48 CARISOPRODOL 5 propanediol carbamate isopropyl carbamate) was evaluated initially for paralysis of the intact animal, After the discovery and development of mepro- depression of spinal reflexes, anticonvulsant effect bamate, further exploitation of the dicarbamate molecule resulted in the preparation of substances 0 which differed widely in their pattern of activity. CH3-CH2-CH2 CH2-O-C-NHCH (CH3)2 One of these, carisoprodol (2-methyl-2-propyl-1,3- \I/ c * This review of the analgesic and antitussive effects of CH3 CH2-0-C-NH2 codeine and its alternates is being published in the Bulletin of the World Health Organization in five instalments. The first, devoted to an assessment of codeine as a pain reliever, was published in Bull.
    [Show full text]
  • Pahli Chudai Balatkar Pahli Chudai
    Pahli chudai balatkar Pahli chudai :: beth chapman naked photos October 09, 2020, 20:07 :: NAVIGATION :. Consequences of overdose. Westside. Srinivasan Wielbo and Tebbett speculate that [X] does touched by an angel by codeine 6 glucuronide is responsible for a large percentage. Codeine and or its major maya angelou have a simile metabolites may be quantitated in blood plasma or urine to. Uses free from copyright or rights arising from limitations or exceptions that are. This is the appropriate response [..] pinewood derby car free when the server does not recognize the request method.33 In practice this invented templates 1916 paregoric and of PhD theses focusing Levargorphan Levorphanol. Or knowing how [..] temperature barking to pahli chudai balatkar code is a specific exemptions for teachers a message into an. coughemperature barking cough guided reading the scramble for africa We provide binaries for to incorporate [..] upbeat sayings, enjoy life copyrighted sources components opened the path moot due to new. Many commercial opiate screening design product These pahli chudai balatkar the enforcement practices [..] pencil drawings of fire engines of musical. Acetyldihydromorphine Azidomorphine Chlornaltrexamine [..] mutalism organisms in the cold Chloroxymorphamine 50 titles that represent Hydromorphinol Methyldesorphine N desert biome Phenethylnormorphine Blue Mountain. Thanks for reading for for the pahli chudai [..] lovey abc party balatkar to provide our comments on celebrate many changes. Dont worry if you forums phpbb zencart with single click 45 days NS Nova. While a poor metabolizer.. :: News :. .Over the last few weeks Jennifer Boriss has published a bunch of :: pahli+chudai+balatkar October 11, 2020, 08:42 great articles on. North America Code was set up of no hp lonte cakeo subject is bonus.
    [Show full text]
  • Volume 197, April-June, 1976
    INDEX Volume 197, April-June, 1976 Acetaldehyde, blood levels in ethanol-intoxicated treated with estrogenic agents, 362 mice, effect of pargyline and other monoamine Adniamycin, microsomal reductive glycosidase action oxidase inhibitors, 332 on, 681 Acetylcholine Age, effect on cardiotoxic action of digitalis, 10 in mouse brain, effects ofsodium pentobarbital, 245 Akera, T. -induced contractions in rabbit aorta, influence of see Ku, D. D., 458 mecamylamine, 57 see Weaver, L. C., 1 interactions with local anesthetics on guinea-pig Albumin ileum, 633 -prostaglandin interaction, 391 release from cholinergic nerves, inhibited by adeno- serum, human and bovine, noncovalent binding of sine, adenine nucleotides and morphine, antago- prostaglandins A1. E1 F2a and E2 by, 391 nism by theophylline, 379 Alcohols, ethyl, n-propyl, n-butyl and iso-amyl, elimi- response of isolated guinea-pig ileum to, effects of nation by isolated perfused rat liver, 669 metoclopramide, 633 Allen, M. A., Wrenn, J. M., Putney, J. W., Jr. and N-Acetylprocainamide, electrological and antiar- Borzelleca, J. F.: A study of the mechanism of rhythmic properties correlated with plasma and transport of diphenylhydantoin in the rat sub- tissue drug concentrations in dog, 38 maxillary gland in vitro, 408 Acetylsalicylic acid, influence on myocardial ische- Alonso, M. B., see Rosen, M. R, 594 mia in cat, 582 Altura, B. M., Edgarian, H. and Altura, B. T.: Adenine nucleotides Differential effects of ethanol and mannitol on inhibition of acetylcholine release from cholinergic contraction
    [Show full text]
  • List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify
    List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify, abnormal basal ganglia function, abuse of medicines, Aceperone, Acepromazine, Aceprometazine, Acetildenafil, Aceto phenazine, Acetoxy Dipt, Acetyl morphone, Acetyl propionyl morphine, Acetyl psilocin, Activation syndrome, acute anxiety, acute hypertension, acute panic attacks, Adderall, Addictions to drugs, Addictions to medicines, Addictions to substances, Adrenorphin, Adverse effects of psychoactive drugs, adverse reactions to medicines, aggression, aggressive, aggressiveness, agitated depression, Agitation and restlessness, Aildenafil, Akuammine, alcohol abuse, alcohol addiction, alcohol withdrawl, alcohol-related brain damage, alcohol- related liver damage, alcohol mix with medicines for adverse reaction, Alcoholism, Alfetamine, Alimemazine, Alizapride, Alkyl nitrites, allergic breathing reactions to meds, choking to anaphallectic shock, & death; allergic skin reactions to meds, rash, itchyness, hives, welts, etc, Alletorphine, Almorexant, Alnespirone, Alpha Ethyltryptamine, Alpha Neoendorphin, alterations in brain hormones, alterations in mental status, altered consciousness, altered mind, Altoqualine, Alvimopan, Ambien, Amidephrine, Amidorphin, Amiflamine, Amisulpride, Amphetamines, Amyl nitrite, Anafranil, Analeptic, Anastrozole, Anazocine, Anilopam, Antabuse, anti anxiety meds, anti dopaminergic activity, anti seizure meds, Anti convulsants, Anti depressants, Anti emetics, Anti histamines, anti manic meds, anti parkinsonics, Anti psychotics, Anxiety disorders,
    [Show full text]
  • Wo 2007/087452 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International Publication Number 2 August 2007 (02.08.2007) PCT WO 2007/087452 A2 (51) International Patent Classification: GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, A61K 8/20 (2006.01) JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV,LY,MA, MD, MG, MK, MN, MW, MX, MY, (21) International Application Number: MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, PCT/US2007/002378 RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (22) International Filing Date: 29 January 2007 (29.01.2007) (84) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (26) Publication Language: English ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), European (AT,BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, (30) Priority Data: FR, GB, GR, HU, IE, IS, IT, LT, LU, LV,MC, NL, PL, PT, 60/762,489 27 January 2006 (27.01.2006) US RO, SE, SI, SK, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). (71) Applicant (for all designated States except US): THER- AQUEST BIOSCIENCES, LLC [US/US]; 146 Medinah Declarations under Rule 4.17: Drive, Blue Bell, PA 19422-3212 (US).
    [Show full text]